L&G Healthcare Technology & Innovation UCITS ETF USD Acc (DOCT)
LSE
Real-time Data
07:00 AM
Day's Range
17.9252 wk Range
12.35Profile - DOCT - L&G Healthcare Technology & Innovation UCITS ETF USD Acc
Profile
Mic Code
XLON
Sector
Basic Materials
Industry
Specialty Chemicals
Employees
0
L&G Healthcare Technology & Innovation UCITS ETF USD Acc is an accumulating exchange-traded fund that tracks the ROBO Global Healthcare Technology and Innovation Index. It provides targeted exposure to global companies at the forefront of healthcare innovation, including those in biotechnology, pharmaceuticals, medical devices, diagnostic tools, and healthcare services. These firms focus on breakthrough treatments, cutting-edge technologies, and solutions addressing critical health challenges, with heavy emphasis on North America (around 72%) and sectors like industrials, healthcare, and technology. Managed by Legal & General Investment Management, one of Europe's largest asset managers, the ETF features a total expense ratio of 0.49% and reinvests dividends to support compound growth. Notable holdings include Moderna Inc., Guardant Health Inc., and Thermo Fisher Scientific Inc., representing key innovators in genomics, diagnostics, and life sciences. Launched in 2019 and domiciled in Ireland, it offers diversified access to the evolving healthcare technology landscape, appealing to those tracking advancements in medical R&D and patient outcomes.
Profile Details
Type
ETF
Ceo
Mr. Ahmed Khaled El-Hoshy
Address
Honthorststraat 19
City
Amsterdam
State
MI
Zip
1071 DC
Country
Netherlands
Phone
+44 20 7355 9810
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
